FDA approves Gadavist (gadobutrol), a macrocyclic gadolinium contrast agent for CNS imaging. PDF Print
FDA: The U.S. Food and Drug Administration approved Gadavist (gadobutrol), a gadolinium-based contrast agent, for use in patients undergoing magnetic resonance imaging (MRI) of the central nervous system.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.